3-(2,5-Dichloropyrimidin-4-yl)imidazo[1,2-a]pyridine → 1-[4-[4-[(5-Chloro-4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]-2,5-dimethoxyphenyl]piperazin-1-yl]ethanone

HRID 113

반응식

HRID 113 반응식
COc1cc(N2CCN(C(C)=O)CC2)c(OC)cc1N.Clc1ncc(Cl)c(-c2cnc3ccccn23)n1>C1COCCO1.CC(=O)O.CC(=O)O.CC1(C)c2cccc(P(c3ccccc3)c3ccccc3)c2Oc2c(P(c3ccccc3)c3ccccc3)cccc21.O=C([O-])[O-].[Cs+].[Cs+].[Pd]>COc1cc(N2CCN(C(C)=O)CC2)c(OC)cc1Nc1ncc(Cl)c(-c2cnc3ccccn23)n1

참가 물질

7

반응물 2

HCID 469346053-(2,5-Dichloropyrimidin-4-yl)imidazo[1,2-a]pyridineHCID 685924151-(4-(4-Amino-2,5-dimethoxyphenyl)piperazin-1-yl)ethanone

생성물 1

HCID 453819881-[4-[4-[(5-Chloro-4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]-2,5-dimethoxyphenyl]piperazin-1-yl]ethanone수율 0%

시약·촉매·용매 4

HCID 10796Cesium carbonate시약HCID 6360441,1'-(9,9-Dimethyl-9H-xanthene-4,5-diyl)bis(1,1-diphenylphosphine)촉매HCID 4144353Palladium (II) acetate촉매HCID 312751,4-Dioxane용매

반응 조건

온도
80 °C

실험 절차

_3-(2,5-dichloropyrimidin-4-yl)imidazo[1,2-a]pyridine (132.5 mg, 0.50 mmol)_ _ _ _1-(4-(4-amino-2,5-dimethoxyphenyl)piperazin-1-yl)ethanone (140 mg, 0.50 mmol)_ ___(9,9-dimethyl-9H-xanthene-4,5-diyl)bis(diphenylphosphine) (23.14 mg, 0.04 mmol)_ _ _ _cesium carbonate (244 mg, 0.75 mmol)_ ___diacetoxypalladium (4.49 mg, 0.02 mmol)_ _were suspended in_ _1,4-dioxane (4 ml)_ _,degased with argon . The mixture was heated to_ _80 °C_ _ for 2 hrs *_

출처 및 근거

ORD 기록
ord-ea73803169b640e3b40a2b6127b91b44
출처 데이터셋
750 AstraZeneca ELN dataset
원본 링크
출처 보기

연결된 노트

불러오는 중…